IBDEI0Z0 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,45913,0)
 ;;=I63.50^^136^1942^14
 ;;^UTILITY(U,$J,358.3,45913,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45913,1,3,0)
 ;;=3^Cereb infrc due to unsp occls or stenos of unsp cereb artery
 ;;^UTILITY(U,$J,358.3,45913,1,4,0)
 ;;=4^I63.50
 ;;^UTILITY(U,$J,358.3,45913,2)
 ;;=^5007343
 ;;^UTILITY(U,$J,358.3,45914,0)
 ;;=I67.89^^136^1942^36
 ;;^UTILITY(U,$J,358.3,45914,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45914,1,3,0)
 ;;=3^Cerebrovascular Disease,Other
 ;;^UTILITY(U,$J,358.3,45914,1,4,0)
 ;;=4^I67.89
 ;;^UTILITY(U,$J,358.3,45914,2)
 ;;=^5007388
 ;;^UTILITY(U,$J,358.3,45915,0)
 ;;=I69.920^^136^1942^15
 ;;^UTILITY(U,$J,358.3,45915,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45915,1,3,0)
 ;;=3^Cerebrovascular Disease,Aphasia,Unspec
 ;;^UTILITY(U,$J,358.3,45915,1,4,0)
 ;;=4^I69.920
 ;;^UTILITY(U,$J,358.3,45915,2)
 ;;=^5007553
 ;;^UTILITY(U,$J,358.3,45916,0)
 ;;=I69.990^^136^1942^16
 ;;^UTILITY(U,$J,358.3,45916,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45916,1,3,0)
 ;;=3^Cerebrovascular Disease,Apraxia,Unspec
 ;;^UTILITY(U,$J,358.3,45916,1,4,0)
 ;;=4^I69.990
 ;;^UTILITY(U,$J,358.3,45916,2)
 ;;=^5007568
 ;;^UTILITY(U,$J,358.3,45917,0)
 ;;=I69.993^^136^1942^17
 ;;^UTILITY(U,$J,358.3,45917,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45917,1,3,0)
 ;;=3^Cerebrovascular Disease,Ataxia,Unspec
 ;;^UTILITY(U,$J,358.3,45917,1,4,0)
 ;;=4^I69.993
 ;;^UTILITY(U,$J,358.3,45917,2)
 ;;=^5007571
 ;;^UTILITY(U,$J,358.3,45918,0)
 ;;=I69.91^^136^1942^18
 ;;^UTILITY(U,$J,358.3,45918,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45918,1,3,0)
 ;;=3^Cerebrovascular Disease,Cognitive Deficits,Unspec
 ;;^UTILITY(U,$J,358.3,45918,1,4,0)
 ;;=4^I69.91
 ;;^UTILITY(U,$J,358.3,45918,2)
 ;;=^5007552
 ;;^UTILITY(U,$J,358.3,45919,0)
 ;;=I69.922^^136^1942^19
 ;;^UTILITY(U,$J,358.3,45919,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45919,1,3,0)
 ;;=3^Cerebrovascular Disease,Dysarthria,Unspec
 ;;^UTILITY(U,$J,358.3,45919,1,4,0)
 ;;=4^I69.922
 ;;^UTILITY(U,$J,358.3,45919,2)
 ;;=^5007555
 ;;^UTILITY(U,$J,358.3,45920,0)
 ;;=I69.991^^136^1942^20
 ;;^UTILITY(U,$J,358.3,45920,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45920,1,3,0)
 ;;=3^Cerebrovascular Disease,Dysphagia
 ;;^UTILITY(U,$J,358.3,45920,1,4,0)
 ;;=4^I69.991
 ;;^UTILITY(U,$J,358.3,45920,2)
 ;;=^5007569
 ;;^UTILITY(U,$J,358.3,45921,0)
 ;;=I69.921^^136^1942^21
 ;;^UTILITY(U,$J,358.3,45921,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45921,1,3,0)
 ;;=3^Cerebrovascular Disease,Dysphasia
 ;;^UTILITY(U,$J,358.3,45921,1,4,0)
 ;;=4^I69.921
 ;;^UTILITY(U,$J,358.3,45921,2)
 ;;=^5007554
 ;;^UTILITY(U,$J,358.3,45922,0)
 ;;=I69.992^^136^1942^22
 ;;^UTILITY(U,$J,358.3,45922,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45922,1,3,0)
 ;;=3^Cerebrovascular Disease,Facial Weakness
 ;;^UTILITY(U,$J,358.3,45922,1,4,0)
 ;;=4^I69.992
 ;;^UTILITY(U,$J,358.3,45922,2)
 ;;=^5007570
 ;;^UTILITY(U,$J,358.3,45923,0)
 ;;=I69.923^^136^1942^23
 ;;^UTILITY(U,$J,358.3,45923,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45923,1,3,0)
 ;;=3^Cerebrovascular Disease,Fluency Disorder
 ;;^UTILITY(U,$J,358.3,45923,1,4,0)
 ;;=4^I69.923
 ;;^UTILITY(U,$J,358.3,45923,2)
 ;;=^5007556
 ;;^UTILITY(U,$J,358.3,45924,0)
 ;;=I69.952^^136^1942^24
 ;;^UTILITY(U,$J,358.3,45924,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45924,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Dominant Side
 ;;^UTILITY(U,$J,358.3,45924,1,4,0)
 ;;=4^I69.952
 ;;^UTILITY(U,$J,358.3,45924,2)
 ;;=^5133586
 ;;^UTILITY(U,$J,358.3,45925,0)
 ;;=I69.954^^136^1942^25
 ;;^UTILITY(U,$J,358.3,45925,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45925,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Left Nondominant Side
 ;;^UTILITY(U,$J,358.3,45925,1,4,0)
 ;;=4^I69.954
 ;;^UTILITY(U,$J,358.3,45925,2)
 ;;=^5133587
 ;;^UTILITY(U,$J,358.3,45926,0)
 ;;=I69.951^^136^1942^26
 ;;^UTILITY(U,$J,358.3,45926,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45926,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Dominant Side
 ;;^UTILITY(U,$J,358.3,45926,1,4,0)
 ;;=4^I69.951
 ;;^UTILITY(U,$J,358.3,45926,2)
 ;;=^5007561
 ;;^UTILITY(U,$J,358.3,45927,0)
 ;;=I69.953^^136^1942^27
 ;;^UTILITY(U,$J,358.3,45927,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45927,1,3,0)
 ;;=3^Cerebrovascular Disease,Hemiplegia/Hemiparesis,Right Nondominant Side
 ;;^UTILITY(U,$J,358.3,45927,1,4,0)
 ;;=4^I69.953
 ;;^UTILITY(U,$J,358.3,45927,2)
 ;;=^5007562
 ;;^UTILITY(U,$J,358.3,45928,0)
 ;;=I69.942^^136^1942^28
 ;;^UTILITY(U,$J,358.3,45928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45928,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,45928,1,4,0)
 ;;=4^I69.942
 ;;^UTILITY(U,$J,358.3,45928,2)
 ;;=^5133582
 ;;^UTILITY(U,$J,358.3,45929,0)
 ;;=I69.944^^136^1942^29
 ;;^UTILITY(U,$J,358.3,45929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45929,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Lower Nondominant Side
 ;;^UTILITY(U,$J,358.3,45929,1,4,0)
 ;;=4^I69.944
 ;;^UTILITY(U,$J,358.3,45929,2)
 ;;=^5133585
 ;;^UTILITY(U,$J,358.3,45930,0)
 ;;=I69.932^^136^1942^30
 ;;^UTILITY(U,$J,358.3,45930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45930,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,45930,1,4,0)
 ;;=4^I69.932
 ;;^UTILITY(U,$J,358.3,45930,2)
 ;;=^5133580
 ;;^UTILITY(U,$J,358.3,45931,0)
 ;;=I69.934^^136^1942^31
 ;;^UTILITY(U,$J,358.3,45931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45931,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Lt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,45931,1,4,0)
 ;;=4^I69.934
 ;;^UTILITY(U,$J,358.3,45931,2)
 ;;=^5133583
 ;;^UTILITY(U,$J,358.3,45932,0)
 ;;=I69.941^^136^1942^32
 ;;^UTILITY(U,$J,358.3,45932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45932,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Lower Dominant Side
 ;;^UTILITY(U,$J,358.3,45932,1,4,0)
 ;;=4^I69.941
 ;;^UTILITY(U,$J,358.3,45932,2)
 ;;=^5133581
 ;;^UTILITY(U,$J,358.3,45933,0)
 ;;=I69.943^^136^1942^33
 ;;^UTILITY(U,$J,358.3,45933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45933,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,45933,1,4,0)
 ;;=4^I69.943
 ;;^UTILITY(U,$J,358.3,45933,2)
 ;;=^5133584
 ;;^UTILITY(U,$J,358.3,45934,0)
 ;;=I69.931^^136^1942^34
 ;;^UTILITY(U,$J,358.3,45934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45934,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Dominant Side
 ;;^UTILITY(U,$J,358.3,45934,1,4,0)
 ;;=4^I69.931
 ;;^UTILITY(U,$J,358.3,45934,2)
 ;;=^5007558
 ;;^UTILITY(U,$J,358.3,45935,0)
 ;;=I69.933^^136^1942^35
 ;;^UTILITY(U,$J,358.3,45935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45935,1,3,0)
 ;;=3^Cerebrovascular Disease,Monoplegia,Rt Upper Nondominant Side
 ;;^UTILITY(U,$J,358.3,45935,1,4,0)
 ;;=4^I69.933
 ;;^UTILITY(U,$J,358.3,45935,2)
 ;;=^5007559
 ;;^UTILITY(U,$J,358.3,45936,0)
 ;;=I69.998^^136^1942^42
 ;;^UTILITY(U,$J,358.3,45936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45936,1,3,0)
 ;;=3^Cerebrovascular Disease,Sequelae,Unspec
 ;;^UTILITY(U,$J,358.3,45936,1,4,0)
 ;;=4^I69.998
 ;;^UTILITY(U,$J,358.3,45936,2)
 ;;=^5007572
 ;;^UTILITY(U,$J,358.3,45937,0)
 ;;=I69.928^^136^1942^43
 ;;^UTILITY(U,$J,358.3,45937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45937,1,3,0)
 ;;=3^Cerebrovascular Disease,Speech/Language Deficits,Unspec
 ;;^UTILITY(U,$J,358.3,45937,1,4,0)
 ;;=4^I69.928
 ;;^UTILITY(U,$J,358.3,45937,2)
 ;;=^5007557
 ;;^UTILITY(U,$J,358.3,45938,0)
 ;;=I69.965^^136^1942^37
 ;;^UTILITY(U,$J,358.3,45938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45938,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Bilateral,Unspec
 ;;^UTILITY(U,$J,358.3,45938,1,4,0)
 ;;=4^I69.965
 ;;^UTILITY(U,$J,358.3,45938,2)
 ;;=^5007566
 ;;^UTILITY(U,$J,358.3,45939,0)
 ;;=I69.962^^136^1942^38
 ;;^UTILITY(U,$J,358.3,45939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45939,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Dominant Side
 ;;^UTILITY(U,$J,358.3,45939,1,4,0)
 ;;=4^I69.962
 ;;^UTILITY(U,$J,358.3,45939,2)
 ;;=^5133588
 ;;^UTILITY(U,$J,358.3,45940,0)
 ;;=I69.964^^136^1942^39
 ;;^UTILITY(U,$J,358.3,45940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45940,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Lt Nondominant Side
 ;;^UTILITY(U,$J,358.3,45940,1,4,0)
 ;;=4^I69.964
 ;;^UTILITY(U,$J,358.3,45940,2)
 ;;=^5133589
 ;;^UTILITY(U,$J,358.3,45941,0)
 ;;=I69.961^^136^1942^40
 ;;^UTILITY(U,$J,358.3,45941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45941,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Dominant Side
 ;;^UTILITY(U,$J,358.3,45941,1,4,0)
 ;;=4^I69.961
 ;;^UTILITY(U,$J,358.3,45941,2)
 ;;=^5007564
 ;;^UTILITY(U,$J,358.3,45942,0)
 ;;=I69.963^^136^1942^41
 ;;^UTILITY(U,$J,358.3,45942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45942,1,3,0)
 ;;=3^Cerebrovascular Disease,Paralytic Syndrome,Rt Nondominant Side
 ;;^UTILITY(U,$J,358.3,45942,1,4,0)
 ;;=4^I69.963
 ;;^UTILITY(U,$J,358.3,45942,2)
 ;;=^5007565
 ;;^UTILITY(U,$J,358.3,45943,0)
 ;;=G90.50^^136^1942^44
 ;;^UTILITY(U,$J,358.3,45943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45943,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,45943,1,4,0)
 ;;=4^G90.50
 ;;^UTILITY(U,$J,358.3,45943,2)
 ;;=^5004163
 ;;^UTILITY(U,$J,358.3,45944,0)
 ;;=R56.9^^136^1942^45
 ;;^UTILITY(U,$J,358.3,45944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45944,1,3,0)
 ;;=3^Convulsions,Unspec
 ;;^UTILITY(U,$J,358.3,45944,1,4,0)
 ;;=4^R56.9
 ;;^UTILITY(U,$J,358.3,45944,2)
 ;;=^5019524
 ;;^UTILITY(U,$J,358.3,45945,0)
 ;;=G37.9^^136^1942^46
 ;;^UTILITY(U,$J,358.3,45945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,45945,1,3,0)
 ;;=3^Demyelinating Disease of Central Nervous System,Unspec
 ;;^UTILITY(U,$J,358.3,45945,1,4,0)
 ;;=4^G37.9
 ;;^UTILITY(U,$J,358.3,45945,2)
 ;;=^5003828
